Pegcetacoplan for treating complement 3 glomerulopathy or primary immune-complex membranoproliferative glomerulonephritis in people 12 years and over [ID6489]

In development
Reference number: GID-TA11633
Expected publication date: 18 June 2026

Documents

Documents created during the development process.

Draft guidance

Draft guidance
Draft guidance (online commenting)
Draft guidance (downloadable version) (PDF 247 KB)

Published:

13 March 2026
Committee papers (PDF 9.59 MB)

Published:

13 March 2026
Public committee slides (PDF 1.27 MB)

Published:

13 March 2026
Equality impact assessment (downloadable version) (PDF 134 KB)

Published:

13 March 2026

Invitation to participate

Final scope (PDF 147 KB)

Published:

02 July 2025
Final stakeholder list (PDF 134 KB)

Published:

02 July 2025
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 310 KB)

Published:

02 July 2025
Equality impact assessment (scoping) (PDF 113 KB)

Published:

02 July 2025

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: ID6489

Draft matrix post referral (PDF 45 KB)

Published:

17 April 2025
Draft scope post referral (PDF 135 KB)

Published:

17 April 2025

Referral

Referral

Referral

Referral

Topic selection

Topic selection